StonvexLoading…
StonvexStonvexStonvexCore line items from MSGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $1.04B | $1.03B | $887.45M | $821.35M |
Operating Income | $14.81M | $146.04M | $85.17M | $86.08M |
Net Income | $-22.44M | $58.77M | $47.79M | $51.13M |
EPS (Diluted) | $-0.93 | $2.44 | $1.89 | $2.10 |
Total Assets | $1.47B | $1.35B | $1.32B | $1.30B |
Total Liabilities | $1.75B | $1.61B | $1.65B | $1.45B |
Cash & Equivalents | $144.62M | $89.14M | $40.40M | $91.02M |
Free Cash Flow OCF − CapEx | $87.99M | $90.68M | $151.29M | $177.12M |
Shares Outstanding | 24.09M | 24.10M | 24.19M | 24.41M |